By Jeremy          Laurance
        Source: New          Zealand Herald
            A universal mystical experience with life-changing effects can be produced          by the hallucinogen contained in magic mushrooms, scientists claimed yesterday.
       
        Forty years after Timothy Leary, the apostle of drug-induced mysticism,          urged his 1960s hippie followers to "tune in, turn on, and drop out",          researchers at Johns Hopkins University in the US have for the first time          demonstrated that mystical experiences can be produced safely in the laboratory.
       
        They say that there is no difference between drug-induced mystical experiences          and the spontaneous religious ones that believers have reported for centuries.          They are "descriptively identical".
       
        And they argue that the potential of the hallucinogenic drugs, ignored          for decades because of their links with illicit drug use in the 1960s,          must be explored to develop new treatments for depression, drug addiction          and the treatment of intolerable pain.
       
        Anticipating criticism from church leaders, they say they are not interested          in the "Does God exist?" debate. "This work can't and won't          go there."
       
        Interest in the therapeutic use of psychedelic drugs is growing around          the world. In the UK, the Royal College of Psychiatrists debated their          use at a conference in March for the first time for 30 years. A conference          held in Basel, Switzerland, last January, reviewed the growing psychedelic          psychiatry movement.
       
        The drug psilocybin is the active ingredient of magic mushrooms, which          grow wild in Wales and were openly sold in London markets until a change          in the law last year.
       
        For the Johns Hopkins study, 30 middle-aged volunteers who had religious          or spiritual interests attended two eight-hour drug sessions, two months          apart, receiving psilocybin in one session and a non-hallucinogenic stimulant          - Ritalin - in the other. They were not told which drug was which.
       
        One-third described the experience with psilocybin as the most spiritually          significant of their lifetime and two-thirds rated it among their five          most meaningful experiences.
       
        In more than 60 per cent of cases the experience qualified as a "full          mystical experience" based on established psychological scales, the          researchers say. Some likened it to the importance of the birth of their          first child or the death of a parent.
       
        The effects lasted for at least two months. Eight out of 10 of the volunteers          reported moderately or greatly increased wellbeing or life satisfaction.          Relatives, friends and colleagues confirmed the changes.
       
        The study is one of the first in the new discipline of "neurotheology"          -the neurology of religious experience. The researchers, who report their          findings in the online journal Psychopharmacology, say that, though unorthodox,          their aim is to explore the possible benefits of drugs like psilocybin.
       
        Professor Roland Griffiths, of the department of neuroscience and psychiatry          at Johns Hopkins, said: "As a reaction to the excesses of the 1960s,          human research with hallucinogens has been basically frozen in time. I          had a healthy scepticism going into this. [But] under defined conditions,          with careful preparation, you can safely and fairly reliably occasion          what's called a primary mystical experience that may lead to positive          changes in a person.
       
        "It is an early step in what we hope will be a large body of scientific          work that will ultimately help people."
       
        A third of the volunteers became frightened during the drug sessions with          some reporting feelings of paranoia.
       
        The researchers say psilocybin is not toxic or addictive, unlike alcohol          and cocaine, but that volunteers must be accompanied throughout the experience          by people who can help them through it.
       
        The study is hailed as a landmark by former director of the National Institute          on Drug Abuse, Charles Schuster, in a commentary published alongside the          research.
       
        In a second commentary, Huston Smith, America's leading authority on comparative          religion, writes that mystical experience "is as old as humankind"          and attempts to induce it using psychoactive plants were made in some          ancient cultures, such as classical Greece, and in some contemporary small-scale          cultures.
       
        "But this is the first scientific demonstration in 40 years, and          the most rigorous ever, that profound mystical states can be produced          safely in the laboratory. The potential is great."
Source: http://www.mindpowernews.com
 
 
Sem comentários:
Enviar um comentário